V

Vistin Pharma ASA
OSE:VISTN

Watchlist Manager
Vistin Pharma ASA
OSE:VISTN
Watchlist
Price: 23.2 NOK -0.85%
Market Cap: 1B NOK
Have any thoughts about
Vistin Pharma ASA?
Write Note

Intrinsic Value

The intrinsic value of one VISTN stock under the Base Case scenario is 22.56 NOK. Compared to the current market price of 23.2 NOK, Vistin Pharma ASA is Overvalued by 3%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

VISTN Intrinsic Value
22.56 NOK
Overvaluation 3%
Intrinsic Value
Price
V
Worst Case
Base Case
Best Case

Valuation History
Vistin Pharma ASA

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
VISTN
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for VISTN cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about VISTN?
Bearish
Neutral
Bullish

Fundamental Analysis

23.2 NOK
-0.85%
-0.85%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Vistin Pharma ASA
NO
Pharmaceuticals
Market Cap
1B NOK
IPO
Jun 10, 2015
Employees
-
Norway
Market Cap
1B NOK
Industry
Pharmaceuticals
IPO
Jun 10, 2015
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Vistin Pharma ASA

Provide an overview of the primary business activities
of Vistin Pharma ASA.

What unique competitive advantages
does Vistin Pharma ASA hold over its rivals?

What risks and challenges
does Vistin Pharma ASA face in the near future?

Summarize the latest earnings call
of Vistin Pharma ASA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Vistin Pharma ASA.

Provide P/S
for Vistin Pharma ASA.

Provide P/E
for Vistin Pharma ASA.

Provide P/OCF
for Vistin Pharma ASA.

Provide P/FCFE
for Vistin Pharma ASA.

Provide P/B
for Vistin Pharma ASA.

Provide EV/S
for Vistin Pharma ASA.

Provide EV/GP
for Vistin Pharma ASA.

Provide EV/EBITDA
for Vistin Pharma ASA.

Provide EV/EBIT
for Vistin Pharma ASA.

Provide EV/OCF
for Vistin Pharma ASA.

Provide EV/FCFF
for Vistin Pharma ASA.

Provide EV/IC
for Vistin Pharma ASA.

What are the Revenue projections
for Vistin Pharma ASA?

How accurate were the past Revenue estimates
for Vistin Pharma ASA?

What are the Net Income projections
for Vistin Pharma ASA?

How accurate were the past Net Income estimates
for Vistin Pharma ASA?

What are the EPS projections
for Vistin Pharma ASA?

How accurate were the past EPS estimates
for Vistin Pharma ASA?

What are the EBIT projections
for Vistin Pharma ASA?

How accurate were the past EBIT estimates
for Vistin Pharma ASA?

Compare the revenue forecasts
for Vistin Pharma ASA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Vistin Pharma ASA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Vistin Pharma ASA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Vistin Pharma ASA compared to its peers.

Compare the P/E ratios
of Vistin Pharma ASA against its peers.

Discuss the investment returns and shareholder value creation
comparing Vistin Pharma ASA with its peers.

Analyze the financial leverage
of Vistin Pharma ASA compared to its main competitors.

Show all profitability ratios
for Vistin Pharma ASA.

Provide ROE
for Vistin Pharma ASA.

Provide ROA
for Vistin Pharma ASA.

Provide ROIC
for Vistin Pharma ASA.

Provide ROCE
for Vistin Pharma ASA.

Provide Gross Margin
for Vistin Pharma ASA.

Provide Operating Margin
for Vistin Pharma ASA.

Provide Net Margin
for Vistin Pharma ASA.

Provide FCF Margin
for Vistin Pharma ASA.

Show all solvency ratios
for Vistin Pharma ASA.

Provide D/E Ratio
for Vistin Pharma ASA.

Provide D/A Ratio
for Vistin Pharma ASA.

Provide Interest Coverage Ratio
for Vistin Pharma ASA.

Provide Altman Z-Score Ratio
for Vistin Pharma ASA.

Provide Quick Ratio
for Vistin Pharma ASA.

Provide Current Ratio
for Vistin Pharma ASA.

Provide Cash Ratio
for Vistin Pharma ASA.

What is the historical Revenue growth
over the last 5 years for Vistin Pharma ASA?

What is the historical Net Income growth
over the last 5 years for Vistin Pharma ASA?

What is the current Free Cash Flow
of Vistin Pharma ASA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Vistin Pharma ASA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Vistin Pharma ASA

Current Assets 143.8m
Cash & Short-Term Investments 5.6m
Receivables 65.8m
Other Current Assets 72.4m
Non-Current Assets 244.1m
Long-Term Investments 11.4m
PP&E 230.3m
Other Non-Current Assets 2.4m
Current Liabilities 67.4m
Accounts Payable 18.3m
Short-Term Debt 5.6m
Other Current Liabilities 43.5m
Non-Current Liabilities 9.8m
Other Non-Current Liabilities 9.8m
Efficiency

Earnings Waterfall
Vistin Pharma ASA

Revenue
423.6m NOK
Cost of Revenue
-149m NOK
Gross Profit
274.6m NOK
Operating Expenses
-192m NOK
Operating Income
82.7m NOK
Other Expenses
-21.3m NOK
Net Income
61.4m NOK
Fundamental Scores

VISTN Profitability Score
Profitability Due Diligence

Vistin Pharma ASA's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
ROE is Increasing
ROIC is Increasing
54/100
Profitability
Score

Vistin Pharma ASA's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

VISTN Solvency Score
Solvency Due Diligence

Vistin Pharma ASA's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
77/100
Solvency
Score

Vistin Pharma ASA's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VISTN Price Targets Summary
Vistin Pharma ASA

There are no price targets for VISTN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for VISTN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one VISTN stock?

The intrinsic value of one VISTN stock under the Base Case scenario is 22.56 NOK.

Is VISTN stock undervalued or overvalued?

Compared to the current market price of 23.2 NOK, Vistin Pharma ASA is Overvalued by 3%.

Back to Top